Therefore, L-364,718, a CCK1 receptor antagonist, and LY-288,513, a CCK2 receptor antagonist (0.01-10 μM), were utilised to examine endogenous CCK regulation of the development of morphine dependence in SH-SY5Y cells. The gene discussed is CCK; the disease is morphine dependence.